Navigation Links
New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey
Date:10/8/2008

ess, profile, irregularities in the bridge, bumps, reducing or enlarging the tip, tip asymmetries and changing the position of the nostrils are some of the more common complaints he addresses.

Using Dr. Parker's favorite visual communication tool, computer imaging, a patient can see their own "before and after." Dr. Parker says, "A picture is worth a thousand words. We use computer imaging extensively to give our patients a sense of what can be accomplished. It serves as an excellent medium to put the patient and me on the same page. I then take the imaged pictures with me to the operating room and use them as a sculptor uses his sketches to guide his hand."

Liz, the Parker Center's imaging technician, is one of the most experienced professionals in the country. In fact, she has trained plastic surgeons and their staff members around the country. Dr. Parker comments on the benefits of imaging, "Patients quickly see the importance of harmony and balance and how the nose must be in concert with the rest of the face."

Postoperative pictures of Dr. Parker's patients consistently confirm the accuracy of the imaging process in predicting postoperative results. This type of predictability requires both an expert imager and expert surgeon working together on a daily basis so that both are aware of one another's capabilities.   

Dr. Parker prefers an open rhinoplasty technique, in most cases. Here, the skin is lifted up like a curtain after a small incision is made at the base of the columella allowing cartilage and bone to be exposed. Dr. Parker again, "In a closed approach the surgeon cannot see the structures as well. Clear visibility is helpful when making anatomic changes. If things look good on the inside, then they will almost always look good on the outside. I can accurately determine how much to remove or leave behind for the best result--altering as I go."

Acc
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
2. New Jersey Hospital to Pay $3.85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement
3. HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital
4. Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion
5. Cosmetic Surgery for Men in New Jersey is Seeing a Dramatic Increase at Parker Center for Plastic Surgery
6. Building the New Majority Launches Grassroots GOP Effort in New Jersey
7. Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundations Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in New Jersey Participating
8. ISI Receives New ISO 9001:2000 Certifications in California and New Jersey
9. New Jersey Coalition Calls for Investigation of Private Wells to Protect Families from PFOA in Drinking Water
10. Princeton HealthCare System Foundation Launches $115 Million Capital Campaign for New Hospital in New Jersey
11. New Jersey Dermatologist Volunteers Show Golf Enthusiasts How to Play Safe in the Sun
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey
New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7President Announces Free Health Plan 58446 1President Announces Free Health Plan 58446 2President Announces Free Health Plan 58446 3Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 1Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 2Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 3Crisis in Aging 3A Disability and Alzheimer 26apos 3Bs 3A Lack of Caregivers Threatens South Florida Seniors 26apos 3B Ability to Stay Home 58441 4Scientists find obesity alone does not cause arthritis in animals 58436 1Scientists find obesity alone does not cause arthritis in animals 58436 2Scientists find obesity alone does not cause arthritis in animals 58436 3